Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Residual TP53 Mutation Contributes to Chemoresistance through Clonal Expansion in Acute Myeloid Leukemia

Bowen Yan, PhD, Qinwei Chen, MS, Jianfeng Xu, PhD, Wei Li, PhD, Bing Xu, Suming Huang, PhD, Yi Qiu, PhD

Blood (2019) 134 (Supplement_1): 2731.

https://doi.org/10.1182/blood-2019-127511

Published: 2019

Journal Articles

Chimeric Antigen Receptor-Engineered Exosome As a Drug Delivery System in Mantle Cell Lymphoma

Huijing Bao, PhD, Chengfeng Bi, MD PhD, Wei Li, PhD, Xuhan Zhang, Huilai Zhang, Bin Meng, Kai Fu, MD PhD

Blood (2017) 130 (Supplement 1): 5561.

https://doi.org/10.1182/blood.V130.Suppl_1.5561.5561

Published: 2017

Journal Articles

DNA Epigenome Editing Using Crispr-Cas Suntag-Directed DNMT3A

Yung-Hsin Huang, BS, Su Jianzhong, PhD, Yong Lei, PhD, Michael C Gundry, BS, Xiaotian Zhang, BS, Mira Jeong, PhD, Wei Li, PhD, Margaret A Goodell, PhD

Blood (2016) 128 (22): 2707.

https://doi.org/10.1182/blood.V128.22.2707.2707

Published: 2016

Journal Articles

Dnmt3a and Tet2 interact to Repress differentiation lineage-specific transcriptional factors in Hematopoietic Stem Cells By the Regulation of Epigenome

Xiaotian Zhang, BS, Mira Jeong, PhD, Jianzhong Su, Myung Gon Ko, PhD, Yun Huang, PhD, Hyun Jung Park, Anjana Rao, PhD, Wei Li, PhD, Margaret A. Goodell, PhD

Blood (2014) 124 (21): 242.

https://doi.org/10.1182/blood.V124.21.242.242

Published: 2014

Journal Articles

A Novel Th17-Prone CD146 + CCR5 + T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease

Wei Li, PhD, Liangyi Liu, Aurelie Gomez, MD, Qing Zhang, Jilu Zhang, PhD, Abdulraouf Ramadan, PhD, Christen L Mumaw, BS, Joel K. Greenson, MD, Suntrea Hammer, MD, Jingmei Lin, MD PhD, Thomas M. Braun, PhD, Di Jiang, Elizabeth Virts, PhD, Stephanie L Kelich, Hong Wei Chu, MD PhD, Samir Hanash, MD PhD, Helmut Hanenberg, MD, Sophie Paczesny, MD PhD

Blood (2014) 124 (21): 3.

https://doi.org/10.1182/blood.V124.21.3.3

Published: 2014

Journal Articles

Anti-Myeloma and Anti-Angiogenic Effects of the Novel Anthracycline Derivative INNO-206

Eric Sanchez, Mingjie Li, Cathy Wang, Alex de Castro Abeger, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2010) 116 (21): 4065.

https://doi.org/10.1182/blood.V116.21.4065.4065

Published: 2010

Journal Articles

Efficacy and Tolerability of CEP-18770 In Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Eric Sanchez, Mingjie Li, Cathy Wang, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2010) 116 (21): 4066.

https://doi.org/10.1182/blood.V116.21.4066.4066

Published: 2010

Journal Articles

Multiple Myeloma (MM) Highly Expresses CGEN-928 and the Anti-CGEN-928 TM21 Antibody Markedly Inhibits the Growth of MM Cells and Enhances the Anti-Myeloma Effects of Dexamethasone, Melphalan and Bortezomib

Haiming Chen, MD, PhD, Mingjie Li, Cathy Wang, Jessica Wang, Eric Sanchez, Zhi-Wei Li, PhD, Benjamin Bonavida, PhD, Ofer Levy, Liat Dassa, Gady Cojocaru, MD, James R. Berenson, MD, Zurit Levine, PhD

Blood (2010) 116 (21): 4067.

https://doi.org/10.1182/blood.V116.21.4067.4067

Published: 2010

Journal Articles

Blockage of TRAF6 by Dominant Negative Peptides to Inhibit Multiple Myeloma (MM) Cell Proliferation and Osteoclast Formation through NF-κB, JNK and AKT Signal Transduction Pathways

Mingjie Li, Eric Sanchez, Cathy Wang, Megan Schultz, Jessica Wang, Emily Wong, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, Eddie E Chou, James R. Berenson, MD

Blood (2010) 116 (21): 4068.

https://doi.org/10.1182/blood.V116.21.4068.4068

Published: 2010

Journal Articles

Lack of Binding of Monoclonal Protein Produced by Multiple Myeloma (MM) Cells to FcγRIIb Reduces Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling and Provides the Rationale for a Novel Therapeutic Approach to MM

Jennifer Li, Mingjie Li, Cathy Wang, Jessica Wang, Eric Sanchez, Zhi-Wei Li, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2010) 116 (21): 455.

https://doi.org/10.1182/blood.V116.21.455.455

Published: 2010

Journal Articles

Using SCID-Hu Models to Evaluate the Sequencing of Bortezomib Therapy for Multiple Myeloma (MM)

Eric Sanchez, PhD, Mingjie Li, PhD, Cathy Wang, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, Jacqueline Hilger, MS, Barbara Hibner, PhD, James R. Berenson, MD

Blood (2010) 116 (21): 5012.

https://doi.org/10.1182/blood.V116.21.5012.5012

Published: 2010

Journal Articles

Synergistic Anti-Myeloma Effects of the Lyn Kinase Inhibitor INNO-406 In Combination with Doxorubicin, Melphalan and Bortezomib

Zhi-Wei Li, PhD, Eric Sanchez, Cathy Wang, Mingjie Li, David Ramirez, Cydney Nichols, Jennifer Li, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2010) 116 (21): 5015.

https://doi.org/10.1182/blood.V116.21.5015.5015

Published: 2010

Journal Articles

Multiple Myeloma-Specific Targeted Therapy: Use of the Tumor Specific Immunoglobulin Gene Sequence to Activate Drugs Only within Tumor Cells.

Zhi-Wei Li, PhD, Dror Shalitin, PhD, Jennifer Finefield, Crystal Leung, Mengyin Hu, Jing Shen, Mingjie Li, Cathy S Wang, Jeffrey A Steinberg, Eric Sanchez, Haiming Chen, MD, PhD, Robert M Williams, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 1851.

https://doi.org/10.1182/blood.V114.22.1851.1851

Published: 2009

Journal Articles

Oral Dosing of the Novel Proteasome Inhibitor CEP-18770 Shows Marked Anti-Myeloma Effects in SCID-Hu Models of Multiple Myeloma.

Eric Sanchez, Mingjie Li, Jeffrey A Steinberg, Cathy S Wang, Jing Shen, Benjamin Bonavida, PhD, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 1840.

https://doi.org/10.1182/blood.V114.22.1840.1840

Published: 2009

Journal Articles

Alpha Lipoic Acid (ALA) Inhibits the Anti-Myeloma Effects of Bortezomib.

Jeffrey A Steinberg, Jing Shen, Eric Sanchez, Haiming Chen, MD, PhD, Zhi-Wei Li, PhD, Jacqueline Hilger, MS, James R. Berenson, MD

Blood (2009) 114 (22): 3832.

https://doi.org/10.1182/blood.V114.22.3832.3832

Published: 2009

Journal Articles

Largazole, a Novel Cyclic Peptide Histone Deacetylase Inhibitor, Demonstrates Anti-MM Effects Alone and Increases the Anti-MM Effects of Bortezomib.

Zhi-Wei Li, PhD, Mengyin Hu, Crystal Leung, Jeffrey A Steinberg, Jing Shen, Mingjie Li, Cathy S Wang, Eric Sanchez, Albert Bowers, Thomas Greshock, Kenneth Miller, Tenaya Newkirk, Nathan West, James E. Bradner, MD, Robert M Williams, PhD, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 4925.

https://doi.org/10.1182/blood.V114.22.4925.4925

Published: 2009

Journal Articles

CC102528: A Novel Histone Deacetylase Inhibitor in the Hydroxamate Family Demonstrates Potent Anti-Myeloma Activity.

Zhi-Wei Li, PhD, Crystal Leung, Mengyin Hu, Jinbao Xiang, Chao Jiang, Jeffrey A Steinberg, Jing Shen, Mingjie Li, Cathy S Wang, Eric Sanchez, Benjamin Bonavida, PhD, Haiming Chen, MD, PhD, Xu Bai, James R. Berenson, MD

Blood (2009) 114 (22): 4927.

https://doi.org/10.1182/blood.V114.22.4927.4927

Published: 2009

Journal Articles

TRAF6-Dominant Negative Peptides Show Potent Inhibitory Effects On Multiple Myeloma, Osteoclast Formation and Bone Resorption.

Mingjie Li, Eric Sanchez, Jennifer Li, Cathy S Wang, Jing Shen, Mengyin Hu, Crystal Leung, Jessica Wang, Emily Wong, Anoushka Adler, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 611.

https://doi.org/10.1182/blood.V114.22.611.611

Published: 2009

Journal Articles

Pterostilbene: A Novel Histone Deacetylase 1 Inhibitor (HDACi1) Demonstrating Efficacy in Multiple Myeloma.

Haiming Chen, MD, PhD, Rui Hao, PhD, Eric Sanchez, Jing Shen, Mingjie Li, Jessica Wang, Emily Wong, Anoushka Adler, Mengyin Hu, Crystal Leung, Cathy S Wang, Zhi-Wei Li, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 3844.

https://doi.org/10.1182/blood.V114.22.3844.3844

Published: 2009

Journal Articles

Pleiotrophin Is Highly Produced by Solid Tumors and Transdifferentiates Human Monocytes Into Endothelial Cells.

Eric Wirtschafter, Emily Wong, Mingjie Li, Eric Sanchez, Cathy S Wang, Jennifer Li, Riley Kessler, Mengyin Hu, Crystal Leung, Zhi-Wei Li, PhD, Haiming Chen, MD, PhD, Benjamin Bonavida, PhD, James R. Berenson, MD

Blood (2009) 114 (22): 3050.

https://doi.org/10.1182/blood.V114.22.3050.3050

Published: 2009

NARROW

Residual TP53 Mutation Contributes to Chemoresistance through Clonal Expansion in Acute Myeloid Leukemia

Chimeric Antigen Receptor-Engineered Exosome As a Drug Delivery System in Mantle Cell Lymphoma

DNA Epigenome Editing Using Crispr-Cas Suntag-Directed DNMT3A

Dnmt3a and Tet2 interact to Repress differentiation lineage-specific transcriptional factors in Hematopoietic Stem Cells By the Regulation of Epigenome

A Novel Th17-Prone CD146 + CCR5 + T-Cell Population As an Early Marker of Intestinal Graft-Versus-Host Disease

Anti-Myeloma and Anti-Angiogenic Effects of the Novel Anthracycline Derivative INNO-206

Efficacy and Tolerability of CEP-18770 In Combination with Dexamethasone and Lenalidomide Using a SCID-Hu Model of Multiple Myeloma (MM)

Multiple Myeloma (MM) Highly Expresses CGEN-928 and the Anti-CGEN-928 TM21 Antibody Markedly Inhibits the Growth of MM Cells and Enhances the Anti-Myeloma Effects of Dexamethasone, Melphalan and Bortezomib

Blockage of TRAF6 by Dominant Negative Peptides to Inhibit Multiple Myeloma (MM) Cell Proliferation and Osteoclast Formation through NF-κB, JNK and AKT Signal Transduction Pathways

Lack of Binding of Monoclonal Protein Produced by Multiple Myeloma (MM) Cells to FcγRIIb Reduces Immunoreceptor Tyrosine-Based Inhibitory Motif (ITIM) Signaling and Provides the Rationale for a Novel Therapeutic Approach to MM

Using SCID-Hu Models to Evaluate the Sequencing of Bortezomib Therapy for Multiple Myeloma (MM)

Synergistic Anti-Myeloma Effects of the Lyn Kinase Inhibitor INNO-406 In Combination with Doxorubicin, Melphalan and Bortezomib

Multiple Myeloma-Specific Targeted Therapy: Use of the Tumor Specific Immunoglobulin Gene Sequence to Activate Drugs Only within Tumor Cells.

Oral Dosing of the Novel Proteasome Inhibitor CEP-18770 Shows Marked Anti-Myeloma Effects in SCID-Hu Models of Multiple Myeloma.

Alpha Lipoic Acid (ALA) Inhibits the Anti-Myeloma Effects of Bortezomib.

Largazole, a Novel Cyclic Peptide Histone Deacetylase Inhibitor, Demonstrates Anti-MM Effects Alone and Increases the Anti-MM Effects of Bortezomib.

CC102528: A Novel Histone Deacetylase Inhibitor in the Hydroxamate Family Demonstrates Potent Anti-Myeloma Activity.

TRAF6-Dominant Negative Peptides Show Potent Inhibitory Effects On Multiple Myeloma, Osteoclast Formation and Bone Resorption.

Pterostilbene: A Novel Histone Deacetylase 1 Inhibitor (HDACi1) Demonstrating Efficacy in Multiple Myeloma.

Pleiotrophin Is Highly Produced by Solid Tumors and Transdifferentiates Human Monocytes Into Endothelial Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only